Pre-earnings options volume in Viking Therapeutics is normal with calls leading puts 9:4. Implied volatility suggests the market is anticipating a move near 5.9%, or 84c, after results are released. Median move over the past eight quarters is 3.2%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VKTX:
- Viking Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
- VKTX Upcoming Earnings Report: What to Expect?
- B. Riley biotechnology analysts to hold an analyst/industry conference call
- Oppenheimer Predicts up to 140% Rally for These 3 Stocks — Here’s Why They Have Solid Upside
- Biotech Alert: Searches spiking for these stocks today